PMC:7068163 / 9414-10036
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 145 | 202-203 | Gene | denotes | E | Gene:43740570 |
| 146 | 180-190 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 147 | 370-380 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 148 | 444-454 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 149 | 579-589 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T35 | 204-208 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T35 | 180-188 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T36 | 370-378 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T37 | 444-452 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T38 | 579-587 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T95 | 83-90 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signals |
| T96 | 128-129 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T97 | 204-208 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
| T98 | 228-230 | http://purl.obolibrary.org/obo/CLO_0054055 | denotes | 71 |
| T99 | 285-287 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T100 | 349-350 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T101 | 391-392 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T75 | 0-197 | Sentence | denotes | For evaluation of assay performance regarding efficiency, linearity and unspecific signals, we used the SuperScript protocol in a direct comparison of 73 samples with the RealStar SARS-CoV-2 assay. |
| T76 | 198-430 | Sentence | denotes | The E gene assays showed 97% (71/73) identical results in both assays (60 negative and 11 positive results as well as two divergent results, both with a positive Real Star SARS-CoV-2 assay and a negative SuperScript protocol assay). |
| T77 | 431-556 | Sentence | denotes | The specific SARS-CoV-2 assays gave in 67 (92%) identical results (60 negative and seven positive) and six divergent results. |
| T78 | 557-622 | Sentence | denotes | Overall, the RealStar SARS-CoV-2 kit seemed to be more sensitive. |